Letter to the Editor: Lapatinib Confounds Post-Hoc Weight Loss Analysis in the ALTTO Trial.

J Natl Compr Canc Netw

bDepartment of Adult Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

Published: January 2022

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2021.7082DOI Listing

Publication Analysis

Top Keywords

letter editor
4
editor lapatinib
4
lapatinib confounds
4
confounds post-hoc
4
post-hoc weight
4
weight loss
4
loss analysis
4
analysis altto
4
altto trial
4
letter
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!